Financials

  • Market Capitalization 1.82 B
  • Employee 110
  • Founded 2024
  • CEO N/A
  • Website www.inhibrx.com
  • Headquarter Delaware, United States
  • FIGI BBG01MS5Q9G3
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-8.74
주가매출액비율
941.13

Related tickers

#이름가격24h %7d %1M %1Y %마켓 캡이전 7일
2048
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.77 USD-3.19%-4.15%+2.85%+98.97%1.88 B USD
2065
VIR
Vir Biotechnology, Inc. - Common Stock
10.83 USD-4.24%+11.19%+25.78%+81.10%1.83 B USD
2071
SEPN
Septerna, Inc. - Common Stock
38.91 USD-3.85%-3.31%+14.44%+76.78%1.82 B USD
2076
NTLA
Intellia Therapeutics, Inc. - Common Stock
12.87 USD-1.83%+2.14%+17.97%-6.20%1.80 B USD

뉴스